| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 07/07/2004 | CN1511159A Nitrogen-based camptothecin derivatives |
| 07/07/2004 | CN1511155A Amido ether substituted imidazoquinolines |
| 07/07/2004 | CN1511040A Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 07/07/2004 | CN1511038A Combination therepy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 07/07/2004 | CN1509761A Cordyceps Eightzhen capsules |
| 07/07/2004 | CN1509753A Chinese medicine for atrophic vaginitis and premature ovarian failure and its use |
| 07/07/2004 | CN1509743A Oral liquid preparing method for lactogenesis |
| 07/07/2004 | CN1509728A Agent for eliminating hematoma of tunica vaginolis testis |
| 07/07/2004 | CN1509720A Progesterone capsule and preparing method thereof |
| 07/07/2004 | CN1509719A Medicine for treating climacteric syndrome |
| 07/07/2004 | CN1509712A Drugs with extracts of racemic plant as estrogens with organic selectivity and without organotropism of womb |
| 07/07/2004 | CN1156451C Betz 2-adrenoceptor agonists |
| 07/07/2004 | CN1156307C Vagina spry cotaining biological active factor |
| 07/07/2004 | CN1156302C Ointment capable of quick sterilizing AIDS, veneral virus and spermatozoa and preparation process thereof |
| 07/06/2004 | US6759431 Compositions and methods for treating or preventing diseases of body passageways |
| 07/06/2004 | US6759430 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/06/2004 | US6759422 Administering benzothiazole compound for therapy, prophylaxis of disease |
| 07/06/2004 | US6759421 Indoline compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759208 Prevention, therapy disease; forming tritiated water; calibration |
| 07/06/2004 | US6758840 Drug delivery device |
| 07/06/2004 | CA2085201C New pyridyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 07/01/2004 | WO2004055009A1 Novel compounds having selective inhibiting efect at gsk3 |
| 07/01/2004 | WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004055005A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004054577A1 Alpha-2-delta ligands to treat ocd and related diseases |
| 07/01/2004 | WO2004054567A1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 07/01/2004 | WO2004054563A1 Alpha-2-delta ligand for the treatment of sexual dysfunction |
| 07/01/2004 | WO2004054559A1 Alpha2delta ligands for different pharmaceutical uses |
| 07/01/2004 | WO2004054544A1 Pharmaceutical composition for transdermal or transmucous administration comprising a progestin or an estrogen, method for preparing same and uses thereof |
| 07/01/2004 | WO2004054516A2 Antagonists for human prolactin |
| 07/01/2004 | WO2004002420A3 Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use |
| 07/01/2004 | WO2003092605A3 Protease inhibitors |
| 07/01/2004 | WO2003086325A3 Cyanamides useful as reversible inhibitors of cysteine proteases |
| 07/01/2004 | WO2003082193A3 Suramin and derivatives thereof as topical microbicide and contraceptive |
| 07/01/2004 | WO2003045369A9 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses |
| 07/01/2004 | US20040127707 Novel phthalazinones |
| 07/01/2004 | US20040127576 Estrogen receptor modulators |
| 07/01/2004 | US20040127537 Stable liquid parenteral parecoxib formulation |
| 07/01/2004 | US20040127528 Metalloproteinase inhibitors |
| 07/01/2004 | US20040127496 Imidazole-2-carboxamide derivatives as raf kinase inhibitors |
| 07/01/2004 | US20040127482 Substituted heterocycle fused gamma-carbolines |
| 07/01/2004 | US20040127481 Administering a therapeutic amount of a lidocaine, verapamil, diltiazem, isometheptene, or lisuride condensation aerosol |
| 07/01/2004 | US20040127474 Contacting the cell with a ptc agonist in a sufficient amount to inhibit the altered growth state, wherein the ptc agonist is a organic molecule having a molecular weight less than about 750 amu for inhibiting an altered growth state of a cell |
| 07/01/2004 | US20040127389 Effervescent solid composition of matter |
| 07/01/2004 | US20040126863 Comprises amino acid sequences for use in identifying modulators for diagnosis and treatment of respiratory and diabetes-induced peripheral vascular diseases; mimetics |
| 07/01/2004 | US20040126418 7-alpha-methyl-19-nortestosterone (MENT); androgens; improved bioavailability |
| 07/01/2004 | US20040126382 Two-step immunization procedure against chlamydia infection |
| 07/01/2004 | US20040126380 Administering a neurotoxin ; therapy for enlargement of prostate gland |
| 07/01/2004 | US20040126329 Delivery of analgesics through an inhalation route |
| 07/01/2004 | US20040126328 Arerosol; heating drug, vaporization, cooling |
| 07/01/2004 | US20040126327 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 07/01/2004 | US20040126326 Delivery of antidepressants through an inhalation route |
| 07/01/2004 | CA2509825A1 Antagonists for human prolactin |
| 07/01/2004 | CA2509611A1 Method of treatment for sexual dysfunction |
| 07/01/2004 | CA2509600A1 Pharmaceutical uses for alpha2delta ligands |
| 07/01/2004 | CA2508045A1 Novel compounds having selective inhibiting efect at gsk3 |
| 06/30/2004 | EP1433485A2 A uro-genital condition treatment system |
| 06/30/2004 | EP1432991A1 Identification and isolation of somatic stem cells and uses thereof |
| 06/30/2004 | EP1432801A2 Receptors and membrane-associated proteins |
| 06/30/2004 | EP1432799A2 Silencing of gene expression by sirna |
| 06/30/2004 | EP1432735A2 Antagonistic anti-htnfsf13b human antibodies |
| 06/30/2004 | EP1432715A2 Pyrimidine derivatives |
| 06/30/2004 | EP1432708A1 Preparation and use of 1,5,6,7-tetrahydropyrrolo 3,2-c]pyridine derivatives for treatment of obesity |
| 06/30/2004 | EP1432706A2 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 06/30/2004 | EP1432698A2 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 06/30/2004 | EP1432691A1 Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity |
| 06/30/2004 | EP1432679A1 Preparation and use of pyrrole derivatives for treating obesity |
| 06/30/2004 | EP1432423A2 Pharmaceutical combinations of pde-v inhibitors and other agents |
| 06/30/2004 | EP1214313B1 Heteroaryloxy propanolamines, preparation method and pharmaceutical compositions containing same |
| 06/30/2004 | EP1019408B1 1,2,3,4-TETRAHYDRO-BENZOFURO[3,2-c]PYRIDINE DERIVATIVES |
| 06/30/2004 | CN1509337A New polynucleotides and polypeptides of IFN alpha-17 gene |
| 06/30/2004 | CN1509286A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509283A Novel pyridyl cyanoguandine compounds |
| 06/30/2004 | CN1509276A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509274A Metallo proteinase inhibitors |
| 06/30/2004 | CN1509273A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509272A Metalloproteinase inhibitors |
| 06/30/2004 | CN1509196A 4(2-butylamino)-2,7-dimethyl-8-(2-methyl(-6-methoxyp-3-yl)pyrazolo-[1,5-A]-1,3,5-triazine as corticotropin releasing factor receptor |
| 06/30/2004 | CN1509182A Use of extracts and preparations from iris plants and tectorigenin as organ selective medicament for treating urethra disease |
| 06/30/2004 | CN1509171A Use of pyrazoline derivatives in preparation of medicament for prevention and/or treatment of proliferative cell diseases |
| 06/30/2004 | CN1508142A Human Testicular specific gene VCX-8r and VCY coding protein biological function |
| 06/30/2004 | CN1508137A 2-phenyl-substituted imidazo-triazone used as phosphodiesterase inhibitor |
| 06/30/2004 | CN1507897A Medicament containing extract from herb of Asiatic Pennywort for treating and preventing proliferation of mammary gland |
| 06/30/2004 | CN1155708C DNA of encoding plasminogen excited protein |
| 06/30/2004 | CN1155602C Thineopyranecarboxyamide derivatives |
| 06/30/2004 | CN1155589C Compounds and methods for modulation of estroglen receptors |
| 06/30/2004 | CN1155398C Compound Chinese medicine and preparing process thereof |
| 06/30/2004 | CN1155389C Compound traditional medicine with piperine for increasing biological utilization of paeoniflorin and its preparing method |
| 06/30/2004 | CN1155385C Formulation comprising testosteron undecanoate and castor oil |
| 06/29/2004 | US6756395 Cyclization of n-(4-cyanomethylphenyl)methanesulfonamides with ethylenediamine to form n-(4-imidazol-2-ylmethyl)-phenyl) -methanesulfonamides; incontinence, sexual dysfunction, nasal congestion, and cns disorders; alpha 1 adrenergic agonists |
| 06/29/2004 | US6756385 Imidazole derivatives |
| 06/29/2004 | US6756381 A purified antitumor agent is crystallized from acetone or dichloromethane |
| 06/29/2004 | US6756375 Estrogen receptor modulation; hormone replacement therapy |
| 06/29/2004 | US6756374 Diaminothiazoles having antiproliferative activity |
| 06/29/2004 | US6756373 Such as 5-(2-butoxy-5-iodo-3-pyridinyl)-3-ethyl-2-(2-methoxy-ethyl)-2,6-dihydro-7h -pyrazolo(4,3-d)pyrimidin-7-one; cyclic guanosine 3',5'-monophosphate phosphodiesterase inhibitors; erectile dysfunction |
| 06/29/2004 | US6756371 Morpholino or thiomorpholino derivatives; respiratory system disorders |
| 06/29/2004 | US6756370 Piperidine alcohols |
| 06/29/2004 | CA2280685C A medicament against infertility and for increasing fertility |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |